Social Solutions News

's stock had its "outperform" rating reiterated by stock analysts at William Blair in a report issued on Friday, StockRatingsNetwork.com reports.

Walgreen Company has been one of my favorite stocks in the market for some time now, and I have recommended it several times.

To earn certification, ETO Impact was tested with the 2014 Edition EHR Test Method, used by testing laboratories and certification bodies to evaluate the conformance and functionality of EHR Modules against the standards, implementation specifications and certification criteria adopted by the Health and Human Services Secretary to support ... (more)

The firm currently has a "buy" rating on the stock. Maxim Group's target price would indicate a potential upside of 30.57% from the company's current price.

The firm set a "market perform" rating on the stock. Shares of Express Scripts traded up 0.94% during mid-day trading on Thursday, hitting $63.60. Express Scripts has a one year low of $49.79 and a one year high of $66.06. The stock's 50-day moving average is currently $57.74. The company has a market cap of $51.995 billion and a P/E ratio of ... (more)

St. Louis-based Express Scripts, one of the country's largest pharmacy benefit companies, is looking for people to fill up to 100 jobs it will soon bring to the Joplin area.

Doctors are diagnosing children with attention deficit disorder at record rates, and New Hampshire is among the states with the greatest increase in diagnoses from 2008 to 2010, according to a nationwide study by Express Scripts, one of the largest pharmacy benefit management organizations in the country.

The American Red Cross Greater St. Louis region has raised more than $540,000 to help communities impacted by the tornadoes that hit Oklahoma last week.

's stock had its "buy" rating restated by stock analysts at TheStreet in a report issued on Tuesday, Analyst Ratings Network reports.

's stock had its "buy" rating reaffirmed by Lazard Capital Markets in a research note issued on Thursday, Analyst Ratings.Net reports.

Spending in the U.S. on specialty drugs used to treat serious diseases is projected to increase 67 percent by the end of 2015, according to a forecast by pharmacy benefit management firm Express Scripts.

"Express Scripts has been reiterated by TheStreet Ratings as a buy with a ratings score of B+. The company's strengths can be seen in multiple areas, such as its robust revenue growth, compelling growth in net income, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and increase in stock ... (more)